Potassium

Hyperkalemia in Patients With Chronic Renal Failure

Stephen L Seliger
Nephrol Dial Transplant . 2019 Dec 1;34(Suppl 3):iii12-iii18
Google Plus
LinkedIn

Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age

J. Ariana Noel, MD; Sarah E. Bota, BSc; William Petrcich, MSc; et al
JAMA Intern Med . 2019 Jun 10;179(8):1025-1033
Google Plus
LinkedIn

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia

Bruce S. Spinowitz, Steven Fishbane, Pablo E. Pergola, Simon D. Roger, Edgar V. Lerma, Javed Butler, Stephan von Haehling, Scott H. Adler, June Zhao, Bhupinder Singh, Philip T. Lavin, Peter A. McCullough, Mikhail Kosiborod, David K. Packham
Clin J Am Soc Nephrol . 2019 Jun 7;14(6):798-809
Google Plus
LinkedIn

An integrated view of potassium homeostasis

Ardalan M, Golzari SE
N Engl J Med. 2015 Oct 29;373(18):1787
Google Plus
LinkedIn

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors

Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y, Wittes J, Christ-Schmidt H, Berman L, Pitt B; OPAL-HK Investigators
N Engl J Med. 2015 Jan 15;372(3):211-21
Google Plus
LinkedIn

Sodium zirconium cyclosilicate in hyperkalemia

Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G, Qunibi W, Pergola P, Singh B
N Engl J Med. 2015 Jan 15;372(3):222-31
Google Plus
LinkedIn

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA
N Engl J Med. 2004 Aug 5;351(6):543-51
Google Plus
LinkedIn

Hypokalemia

Gennari FJ
N Engl J Med 1998; 339:451-458
Google Plus
LinkedIn

ukidneyisup